Addressing Four Critical Challenges in Oncology Trial Design

Over recent years, oncology studies have vastly outnumbered all other areas of clinical research, with no indications of slowing down. This field is rapidly evolving, driven by advancements in genomics and a growing interest in precision medicine, leading to a significant increase in testing biomarker-guided treatments for novel indications. Such research activity now dominates pharmaceutical pipelines, with a rising complexity and intensity that presents unique challenges.

Download the White Paper Here